fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Abbott India Ltd

Abbott India Ltd

Updated on July 14, 2019

Stock/Share Code - ABBOTINDIA

Abbott India is one of the leading multinational pharmaceutical companies in India and operates with an owned manuafcturing facility in Goa and various independent contract/third party manufacturers based across the country.

Below is the details of ABBOTINDIA Abbott India Ltd

Market Cap₹16,527 Cr.
Current Price ₹8,572.8 as on 19 Jul 19
52 Week High / Low Price₹8,834.05 / ₹6,225
Face Value₹10
Stock P/E36.70
Book Value₹945.22
Dividend Yield0.71 %
ROCE40.63 %
ROE26.07 %
Sales Growth (3yrs)12.95 %
SectorPharmaceuticals
IndustryPharmaceuticals - Multinational
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has good consistent profit growth of 23.86% over 5 years Company has been maintaining a healthy dividend payout of 29.66%
Cons: Stock is trading at 8.23 times its book value

Abbott India Ltd Price Chart

Abbott India Ltd Price Chart

Abbott India Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Glaxosmi. Pharma ₹17.25 50.61 ₹21,429.86 Cr. 1.38 ₹123.03 Cr. 18.42 0.35 751.22 25.61
2. Abbott India 36.70 ₹16,527.29 Cr. 0.71 ₹113.19 Cr. 13.10 14.96 906.31 40.63
3. Pfizer ₹3,169.45 33.90 ₹14,545.72 Cr. 0.63 ₹109.47 Cr. 4.75 3.02 535.66 21.48
4. Sanofi India ₹6,022.3 32.19 ₹12,587.28 Cr. 1.53 ₹92.9 Cr. 12.61 16.12 717.30 28.84
5. Merck ₹3,994.3 7.93 ₹6,791.14 Cr. 0.37 ₹40.71 Cr. 109.85 16.58 231.03 19.38
6. Astrazeneca Phar ₹1,891.45 90.45 ₹4,923 Cr. 0.00 ₹9.82 Cr. 204.97 26.25 190.30 18.64
7. Novartis India ₹80.15 54.24 ₹1,714.53 Cr. 1.44 ₹19.53 Cr. -26.22 -11.92 110.38 17.32

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Abbott India Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019
Sales729721747706698931881788845980948906
YOY Sales Growth %14.44%11.11%11.5%3.19%-4.33%29.1%18.08%11.72%21.1%5.24%7.51%14.96%
Expenses624615623643644730718682734786801753
Material Cost %57.51%59.59%59.02%59.85%62.78%56.02%58.24%54.78%56.33%57.14%57.89%55.63%
Employee Cost %11.77%12.04%11.77%12.01%13.85%10.56%10.34%13.65%13.58%10.73%11.22%12.06%
Operating Profit1051061236353201163107111194146153
OPM %14%15%16%9%8%22%19%14%13%20%15%17%
Other Income141414152415195922253829
Interest000211121101
Depreciation444444444445
Profit before tax1151161337273212178159129214180177
Tax %36%35%35%42%34%35%35%37%36%36%35%36%
Net Profit747586424813811510082138117113
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Nov 2006Nov 2007Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018TTM
Sales5105946667619901,4901,6532,2762,2892,6142,9033,2983,679
Sales Growth %%16.48%12.06%14.25%30.09%50.54%10.9%37.71%0.59%14.2%11.02%13.64%%
Expenses4395135906639201,3151,4702,0091,9772,2502,5052,7743,074
Material Cost %69.25%68.73%68.26%66.26%65.39%57.79%58.79%57.01%57.31%57.07%58.98%57.75%%
Manufacturing Cost %1.24%1.41%1.67%1.63%1.58%0.95%1.12%1.28%0.88%0.82%0.82%0.53%%
Employee Cost %5.15%5.54%6.87%7.84%10.92%11.23%12.48%13.17%13.34%13.05%11.9%11.94%%
Other Cost %15.03%15.33%16.3%15.88%19.83%18.25%16.53%16.8%14.84%15.12%14.61%13.88%%
Operating Profit7182769770176183267312365398525605
OPM %14%14%11%13%7%12%11%12%14%14%14%16%16%
Other Income2126262936205149485057117113
Interest0000000003242
Depreciation4679111519221514161617
Profit before tax871029411794180215295344398436621699
Tax %32%33%33%34%35%33%33%33%34%36%37%35%
Net Profit6068637861120145198229255277401450
EPS in Rs36.7243.9443.5853.7738.5253.9065.3471.59101.44120.12130.19188.81
Dividend Payout %45%37%30%30%38%30%25%25%29%29%31%29%

Compounded Sales Growth

  • 10 Years:: 18.69%
  • 5 Years:: 14.82%
  • 3 Years:: 12.95%
  • TTM:: 11.52%

Compounded Profit Growth

  • 10 Years:: 19.69%
  • 5 Years:: 23.86%
  • 3 Years:: 20.77%
  • TTM:: 12.23%

Return on Equity

  • 10 Years:: 24.92%
  • 5 Years:: 24.68%
  • 3 Years:: 23.95%
  • Last Year:: 26.07%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Nov 2006Nov 2007Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital15141414142121212121212121
Equity Capital15.2814.4713.6813.6813.6821.2521.2521.2521.2521.2521.2521.2521.25
Reserves2312172082582925236267679161,1741,3661,6721,987
Borrowings1110000000000
Other Liabilities121100131119152258272363445431688735932
Trade Payables28.6630.8471.0843.1157.75120.9103.47136.26193.6232.94474.73480.66663.52
Total Liabilities3693323533914578029191,1511,3821,6272,0752,4282,941
Fixed Assets313548495080109989610811081105
Gross Block70.5980.0598.72107.1118.21191.81203.65209.23215.65122.83139.69124.25
Accumulated Depreciation39.9644.8550.7958.3168.5112.1594.98110.98119.6114.3730.142.87
CWIP1130101143621
Investments20515000000000000
Other Assets1321463023424077228091,0511,2821,5151,9592,3442,835
Inventories54.7486.3992.12102.38128.59254.9263.63359.05384.13370.1500.63585.33606.79
Trade receivables23.5230.3432.3744.465.28132.61141.03109.18129.15145.02176.22263.44276.11
Cash Equivalents13.1817.22163.54175.61188.51258.95323.34462.84643.89839.421090.921031.351684.29
Loans n Advances40.9611.7113.9319.3924.3950.3557.3378.1684.14115.49146.96411.6260.07
Total Assets3693323533914578029191,1511,3821,6272,0752,4282,941

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Nov 2006Nov 2007Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Cash from Operating Activity413187374624101155215249307153
Profit from operations80.8896.4991.95121.73100.72181.56205.76293.48307.17374.03399.48544.56
Working Capital Changes-13.33-32.631.2-46.35-5.62-97.28-39.78-28.4523.4821.8566.52-186.96
Taxes paid-26.81-33.15-35.94-38.22-49.04-60.21-64.63-109.72-115.87-147.2-158.78-204.9
Cash from Investing Activity-557140-1-1656-59-144-187-77-155-215
Fixed Assets Purchased-4.79-10.94-21.49-7.92-12.13-15.5-17.26-18.05-18.06-22.72-20.66-16.74
Fixed Assets Sold0.832.320.130.10.120.240.2413.952.540.060.140.17
Investments purchased-100.92-98.04-2400-0.2400000-7.51
Investments sold98.97163.2179.890036.9000000
Cash from Financing Activity-32-83-81-23-27-42-42-42-58-80-90-102
Repayment of Borrowings-0.41-0.38-0.27-0.7700000000
Interest Paid-0.12-0.02-0.02-0.2-0.03-0.03-0.02-0.08-0.12-1.01-0.25-0.13
Dividends Paid-30.49-29.63-29.63-22.4-27.2-41.99-41.99-42.27-48.87-65.87-74.37-85
Net Cash Flow44146133381-31-309162-165

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Nov 2006Nov 2007Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
ROCE %41%40%48%33%42%34%39%40%38%34%41%
Debtor Days171918212432311821202229
Inventory Turnover8.427.467.828.577.776.377.316.166.936.676.07

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Abbott India Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.